Haha, in relation to the medical show comment, to be fair, Cochlear chose an excellent name for their company as a 'cochlear implant' is actually the correct term for all hearing implants that work by inserting an electrode array inside the cochlea.
I don't understand how people set the PE ratio? I do recall reading somewhere that PE reflects future earning capacity of a firm?
Like I said in an earlier post, it seems that there are two effects here in play, one being the financial analysts who determine the valuation of the firm, and the other being its reputation within the medical community. In this uncertain economic climate it seems that the analysts have the final say. Let the price fall.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$312.33 |
Change
-6.190(1.94%) |
Mkt cap ! $20.42B | |||
| Open | High | Low | Value | Volume |
| $317.36 | $318.52 | $312.33 | $42.31M | 134.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 482 | $312.09 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $312.50 | 104 | 1 |
View Market Depth
| Last trade - 16.10pm 01/08/2025 (20 minute delay) ? |
| COH (ASX) Chart |